NIFTY : 14,823.15 SENSEX : 48,949.76 USDINR : 73.67 GOLD : 47,810.00
Support: +91 265 2361474
  • Equity
  • Mutual Fund
  • Derivatives
  • Commodity
  • IPO
  • Other Market

Corporate News

As on 04-May-2021  15:34

Aleor Dermaceuticals receives USFDA tentative approval for Metronidazole Gel
Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Metronidazole Gel USP, 1 %.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Metrogel Gel, 1 %, of Galderma Laboratories LP (Galderma). Metronidazole Gel USP, 1 % is indicated for Indicated for the topical treatment of inflammatory lesions of rosacea.

Powered by Capital Market - Live News

Copyright © 2019 VSE Stock Services Limited (“VSSL”). All Rights Reserved Developed and powered by CMOTS Infotech ( ISO 9001:2015 certified )
.